A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 98
[Display Entries]
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : beta-VLDL
Long Form : beta-very low density lipoprotein
No. Year Title Co-occurring Abbreviation
2018 The effect of cholesterol overload on mouse kidney and kidney-derived cells. HCD, ND
2014 Unavailability of liver triacylglycerol increases serum cholesterol concentration induced by dietary cholesterol in exogenously hypercholesterolemic (ExHC) rats. CE, ExHC, LCAT, SD, TAG
2010 Non-HDL-cholesterol/apolipoprotein B ratio: a useful distinguishing feature in the screening for type III hyperlipoproteinemia. apo, HDL-C, type III HL
2005 Role of chondroitin sulphate in the uptake of beta-VLDL by brain cells. APOE, CS, CSPGs, GAG, LDLR, LRP, PGs
2002 beta-very low density lipoprotein enhances inducible nitric oxide synthase expression in cytokine-stimulated vascular smooth muscle cells. IL-1beta, iNOS, NO, VSMC
2002 Intimal smooth muscle cells up-regulate beta-very low density lipoprotein-mediated cholesterol accumulation by enhancing beta-very low density lipoprotein uptake and decreasing cholesterol efflux. I-SMCs, M-SMCs, SMC
2001 Beta-VLDL protects against A beta(1-42) and apoE toxicity in human SH-SY5Y neuroblastoma cells. APOE
2001 Effects of apolipoprotein E (apoE) isoforms, beta-amyloid (Abeta) and apoE/Abeta complexes on protein kinase C-alpha (PKC-alpha) translocation and amyloid precursor protein (APP) processing in human SH-SY5Y neuroblastoma cells and fibroblasts. APOE, APP, PKCalpha
2001 Glycosaminoglycan-lipoprotein interaction. GAGs, LDL, PGs
10  2001 On the anti-atherogenic effect of the antioxidant BHT in cholesterol-fed rabbits: inverse relation between serum triglycerides and atheromatous lesions. BHT
11  2001 Peroxynitrite-modified 99mTc-beta-VLDL: tissue distribution and plasma clearance rate. HC, NC
12  2000 Intracellular trafficking of pigeon beta-very low density lipoprotein and low density lipoprotein at low and high concentrations in pigeon macrophages. LDL
13  2000 Macrophage cholesterol metabolism, apolipoprotein E, and scavenger receptor AI/II mRNA in atherosclerosis-susceptible and -resistant mice. AcLDL, APOE, HDL
14  2000 Relative importance of the LDL receptor and scavenger receptor class B in the beta-VLDL-induced uptake and accumulation of cholesteryl esters by peritoneal macrophages. HDL, LDL, oxLDL, SRB
15  1999 A direct role for the macrophage low density lipoprotein receptor in atherosclerotic lesion formation. LDLR
16  1999 The betaA4 amyloid peptide complexes to and enhances the uptake of beta-very low density lipoproteins by the low density lipoprotein receptor-related protein and heparan sulfate proteoglycans pathway. ---
17  1998 A minimally lipidated form of cell-derived apolipoprotein E exhibits isoform-specific stimulation of neurite outgrowth in the absence of exogenous lipids or lipoproteins. APOE
18  1998 Analysis of two duplications of the LDL receptor gene affecting intracellular transport, catabolism, and surface binding of the LDL receptor. FH, LDL
19  1998 Beta-VLDL accumulation in familial dysbetalipoproteinemia is associated with increased exchange or diffusion of chylomicron lipids to apo B-100 containing triglyceride-rich lipoproteins. alpha-T, apo, FD, RP
20  1998 Differential cellular accumulation/retention of apolipoprotein E mediated by cell surface heparan sulfate proteoglycans. Apolipoproteins E3 and E2 greater than e4. APOE, HSPG
21  1998 Lipoprotein receptors in acute myelogenous leukemia: failure to detect increased low-density lipoprotein (LDL) receptor numbers in cell membranes despite increased cellular LDL degradation. AML, LDL, LRP, RAP
22  1997 Beta-very low density lipoprotein induces triglyceride accumulation through receptor mediated endocytotic pathway in 3T3-L1 adipocytes. TG
23  1997 Comparative effects of bezafibrate and micronised fenofibrate in patients with type III hyperlipoproteinemia. HDL, HLP
24  1997 Regulation of cholesterol synthesis and esterification in primary cultures of macrophages following uptake of chylomicron remnants. CR, LDL
25  1997 Simultaneous labeling of lipoprotein intracellular trafficking in pigeon monocyte-derived macrophages. AcLDL, LDL
26  1996 Apolipoprotein E-containing high density lipoprotein promotes neurite outgrowth and is a ligand for the low density lipoprotein receptor-related protein. AD, APOE, HDL, LRP
27  1996 Receptor pattern formation as a signal for the capture of lipoproteins. FH
28  1996 Study of causes underlying the low atherosclerotic response to dietary hypercholesterolemia in a selected strain of rabbits. DiL-acLDL, HAR, LAR, LDL, PDGF-BB, PMA, SMC, TBARS
29  1996 The distal pathway of lipoprotein-induced cholesterol esterification, but not sphingomyelinase-induced cholesterol esterification, is energy-dependent. ACAT, SMase
30  1995 Abnormal structure and co-operative binding of low-density lipoprotein receptors containing the Glu-80-->Lys mutation. LDL
31  1995 Cholesterol metabolism in monocyte-derived macrophages from macrophage colony-stimulating factor administered rabbits. ACAT, M-CSF
32  1995 Effect and cellular site of action of cysteine protease inhibitors on the cholesterol esterification pathway in macrophages and Chinese hamster ovary cells. ACAT, ALLN, EST
33  1995 Intravenous heparinase inhibits remnant lipoprotein clearance from the plasma and uptake by the liver: in vivo role of heparan sulfate proteoglycans. apo, HSPG, LDL
34  1995 Lipid-regulating action of gemfibrozil in the stroke-prone spontaneously hypertensive rat. HDL, LDL, SHRSP, VLDL
35  1994 Effect of cholesterol feeding on the susceptibility of lipoproteins to oxidative modification. LDL
36  1994 Enhanced binding and uptake of remnant lipoproteins by hepatic lipase-secreting hepatoma cells in culture. apo, HL, HSPG
37  1994 Impact of monocyte colony-stimulating factor upon beta-very low density lipoprotein (beta-VLDL) cholesterol metabolism in tetradecanoyl phorbol acetate-derived THP-1 cells. M-CSF, TPA
38  1994 Macrophages enhance binding of beta-VLDL and cholesterol ester accumulation in cultured aortic smooth muscle cells. SMC
39  1994 Secretion-capture role for apolipoprotein E in remnant lipoprotein metabolism involving cell surface heparan sulfate proteoglycans. apo
40  1994 The actin cytoskeleton is important for the stimulation of cholesterol esterification by atherogenic lipoproteins in macrophages. ACAT
41  1994 Variable heparan sulfate proteoglycan binding of apolipoprotein E variants may modulate the expression of type III hyperlipoproteinemia. apo, HSPG, LDL
42  1993 Beta-VLDL in hepatic lipase deficiency induces apoE-mediated cholesterol ester accumulation in macrophages. apo
43  1993 Effects of dexamethasone on migration of human monocytes in response to oxidized beta-very low density lipoprotein. ---
44  1993 Hepatic lipase function and the accumulation of beta-very-low-density lipoproteins in the plasma of cholesterol-fed rabbits. ---
45  1993 Hepatic uptake of beta-VLDL in cholesterol-fed rabbits. apo
46  1993 Infusion of atherogenic lipoprotein particles increases hepatic lipase activity in the rabbit. HDL
47  1993 Macrophage-conditioned medium and beta-VLDLs enhance cholesterol esterification in SMCs and HSFs by LDL receptor-mediated and other pathways. CE, HSFs, LDL, SMCs
48  1993 Removal of 14 N-terminal amino acids of lactoferrin enhances its affinity for parenchymal liver cells and potentiates the inhibition of beta- very low density lipoprotein binding. APM
49  1993 Role of heparan sulfate proteoglycans in the binding and uptake of apolipoprotein E-enriched remnant lipoproteins by cultured cells. apo, CHO, FH, LDL, LRP
50  1993 Type III hyperlipoproteinemic phenotype in transgenic mice expressing dysfunctional apolipoprotein E. type III HLP
51  1992 Cholesterol metabolism in ExHC (exogenous hypercholesterolemic) rats. ExHC, SD
52  1992 Effect of perindopril on the development of atherosclerosis in the cholesterol-fed rabbit. ---
53  1992 Effects of apolipoprotein E, beta-very low density lipoproteins, and cholesterol on the extension of neurites by rabbit dorsal root ganglion neurons in vitro. LDL
54  1992 Effects of dexamethasone on experimental atherosclerosis in cholesterol-fed rabbits. ---
55  1992 Identification and properties of the proline664-leucine mutant LDL receptor in South Africans of Indian origin. EGF, FH, LDL
56  1992 Low density lipoprotein receptor-related protein and gp330 bind similar ligands, including plasminogen activator-inhibitor complexes and lactoferrin, an inhibitor of chylomicron remnant clearance. LRP
57  1992 Quantification of the accumulation and degradation of beta-very-low-density lipoproteins in vivo using a 19F-containing residualizing label and n.m.r. spectroscopy. DLBA
58  1991 Beta-VLDL increases endothelial cell plasma membrane cholesterol. MDA-LDL
59  1991 Clearance of chylomicron remnants by the low density lipoprotein receptor-related protein/alpha 2-macroglobulin receptor. alpha 2M, CR, LRP
60  1991 Comparison of plasma clearance of low density lipoprotein with beta-very low density lipoprotein or acetoacetylated low density lipoprotein in cholesterol-fed rabbits. LDL
61  1991 Failure of the intracellular itinerary of beta very low density lipoproteins to augment cholesterol esterification in macrophages from Watanabe heritable hyperlipidemic rabbits. NZ, WHHL
62  1991 Increased removal of beta-very low density lipoproteins after ethinyl estradiol is associated with increased mRNA levels for hepatic lipase, lipoprotein lipase, and the low density lipoprotein receptor in Watanabe heritable hyperlipidemic rabbits. EE, HL, LDL, LPL, WHHL
63  1991 Isolation and characterization of three endosomal fractions from the liver of normal rats after lipoprotein loading. MVBs
64  1991 Lipoproteins activate acyl-coenzyme A:cholesterol acyltransferase in macrophages only after cellular cholesterol pools are expanded to a critical threshold level. ACAT, acetyl-LDL
65  1991 Macrophage-derived foam cells freshly isolated from rabbit atherosclerotic lesions degrade modified lipoproteins, promote oxidation of low-density lipoproteins, and contain oxidation-specific lipid-protein adducts. LDL, MFC, MPM
66  1991 Oxidation of beta-very low density lipoprotein by endothelial cells enhances its metabolism by smooth muscle cells in culture. ECs, SMCs, TBA
67  1991 The influence of particle size and multiple apoprotein E-receptor interactions on the endocytic targeting of beta-VLDL in mouse peritoneal macrophages. ACAT, Apo, LDL
68  1991 Vastatins inhibit cholesterol ester accumulation in human monocyte-derived macrophages. LDL
69  1990 Apolipoprotein C-I modulates the interaction of apolipoprotein E with beta-migrating very low density lipoproteins (beta-VLDL) and inhibits binding of beta-VLDL to low density lipoprotein receptor-related protein. apo, LRP
70  1990 Differences in the processing of chylomicron remnants and beta-VLDL by macrophages. LDL
71  1990 Differential effects of beclobrate on lipid/lipoprotein distribution in normal and hypercholesterolemic rats. APOE, HDL
72  1990 Purification and partial characterization of extracellular liposomes isolated from the hyperlipidemic rabbit aorta. CE, EL, LDL, LP, PL, TBAR, TG, UC
73  1990 The effect of perfluorochemical artificial blood on lipoprotein metabolism in rats. LDL, RBC
74  1989 Beta-very low density lipoprotein uptake in cultured fibroblasts and smooth muscle cells from Watanabe heritable hyperlipidemic rabbits. apo, LDL, WHHL
75  1989 High receptor binding affinity of lipoproteins in atypical dysbetalipoproteinemia (type III hyperlipoproteinemia). dys-beta
76  1989 Macrophages modify beta-VLDL by proteolysis and enhance subsequent lipid accumulation in arterial smooth muscle cells. BHA, DPI, MRPM, PMSF, SMC, TBARS
77  1989 Oxidative modification of beta-very low density lipoprotein. Potential role in monocyte recruitment and foam cell formation. LDL
78  1988 Atherosclerosis and apoprotein E. An enigmatic relationship. ---
79  1988 Effect of endothelium on beta-VLDL metabolism by cultured smooth muscle cells of differing phenotype. CON, EC, IRS, RS, SMC
80  1988 Effects of chylomicron remnants and beta-VLDL on the class and composition of newly secreted lipoproteins by HepG2 cells. ACAT, HMG-CoA
81  1988 Lipoprotein uptake in primary cell cultures of rabbit atherosclerotic lesions. A fluorescence microscopic and flow cytometric study. AcLDL, CE, DiI, LDL, SMCs
82  1988 Metabolism of canine beta-very low density lipoproteins in normal and cholesterol-fed dogs. ---
83  1988 The effect of intravenously injected beta very low density lipoprotein on small and large arterial injuries. ---
84  1988 VLDL apoprotein secretion and apo-B mRNA level in primary culture of cholesterol-loaded rabbit hepatocytes. apo, CH
85  1987 Apoprotein E mediates the interaction of beta-VLDL with macrophages. ---
86  1987 Characterization of lipoprotein receptors on rat Fu5AH hepatoma cells. apo, LDL
87  1987 Inhibition of cholesteryl ester deposition in macrophages by calcium entry blockers: an effect dissociable from calcium entry blockade. ---
88  1987 Monocyte adherence to endothelial cells in vitro is increased by beta-VLDL. VLDL
89  1987 Phospholipid liposomes acquire apolipoprotein E in atherogenic plasma and block cholesterol loading of cultured macrophages. APOE
90  1986 Apolipoprotein E is the determinant that mediates the receptor uptake of beta-very low density lipoproteins by mouse macrophages. methyl beta-VLDL
91  1986 Uptake of canine beta-very low density lipoproteins by mouse peritoneal macrophages is mediated by a low density lipoprotein receptor. LDL, LDL
92  1985 Loci of catabolism of beta-very low density lipoprotein in vivo delineated with a residualizing label, 125I-dilactitol tyramine. 125I-DLT
93  1985 Receptor-mediated uptake of remnant lipoproteins by cholesterol-loaded human monocyte-macrophages. ---
94  1984 Binding of chylomicron remnants and beta-very low density lipoproteins to hepatic and extrahepatic lipoprotein receptors. A process independent of apolipoprotein B48. ---
95  1984 Role of apolipoprotein E in the lipolytic conversion of beta-very low density lipoproteins to low density lipoproteins in type III hyperlipoproteinemia. apoB, LDL
96  1983 Cholesteryl ester accumulation in mouse peritoneal macrophages induced by beta-migrating very low density lipoproteins from patients with atypical dysbetalipoproteinemia. ---
97  1983 Identification of a new structural variant of human apolipoprotein E, E2(Lys146 leads to Gln), in a type III hyperlipoproteinemic subject with the E3/2 phenotype. APOE
98  1982 Structural and metabolic heterogeneity of beta-very low density lipoproteins from cholesterol-fed dogs and from humans with type III hyperlipoproteinemia. ---